B. hinzii is a species of bacteria within the Burkholderia genus, primarily associated with opportunistic infections in immunocompromised individuals. It is clinically significant due to its resistance to multiple antibiotics, complicating treatment options and posing a risk in healthcare settings. An important association is its potential to cause severe respiratory infections, particularly in patients with cystic fibrosis or those with underlying lung conditions.